Login / Signup

Intravenous and subcutaneous administration of trastuzumab in a patient on peritoneal dialysis.

Stefania KokkaliDavid TernantVéronique KemmelDominique LevêqueFréderique WendlingPhilippe BarthelemyJean-Emmanuel Kurtz
Published in: British journal of clinical pharmacology (2021)
Keyphrases
  • peritoneal dialysis
  • end stage renal disease
  • case report
  • epidermal growth factor receptor
  • high dose
  • chronic kidney disease
  • metastatic breast cancer
  • tyrosine kinase